Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.
Open Access
- 1 October 1980
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 152 (4) , 823-841
- https://doi.org/10.1084/jem.152.4.823
Abstract
Established subcutaneous Moloney sarcomas (MST-1) of large size and long duration were eliminated from syngeneic rats by intravenous infusion of varying numbers of specific syngeneic effector T lymphocytes. Spleen cells from BN rats in which tumor had regressed were cultured in an in vitro mixed lymphocyte tumor cell culture (MLTC) to augment cytotoxicity of effector cells. In the MLTC a T cell subset was expanded in response to MST-1 antigens and transformed into blast elements. With these changes, there was an increase in the W3/25 antigen on the T cell surface, a decrease of W3/13 antigen, and an increase in the number of T cells with Ia antigens. The subset associated with elimination of established tumors was a blast T cell W3/25+, W3/13+, as detected by monoclonal antibodies to rat T antigens. The W3/25+ subset was poorly cytotoxic in vitro for MST-1 and apparently functioned in vivo as an amplifier or helper cell in the tumor-bearing host. The W3/25- population was a melange of cells that included (W3/13+, W3/25-) T cells, null cells, Ig+ cells, and macrophages, and was associated with enhancement of tumor in vivo, suggesting the presence of suppressor cells.This publication has 73 references indexed in Scilit:
- T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.The Journal of Experimental Medicine, 1980
- Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells.The Journal of Experimental Medicine, 1979
- Continuous culture of T cells cytotoxic for autologous human leukaemia cellsNature, 1979
- Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 miceInternational Journal of Cancer, 1979
- Adoptive immunochemotherapy of a transplantable AKR leukemia (K36)International Journal of Cancer, 1978
- Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytesCell, 1977
- ADOPTIVE CHEMOIMMUNOTHERAPY OF CANCER IN ANIMALS: A REVIEW OF RESULTS, PRINCIPLES, AND PROBLEMSAnnals of the New York Academy of Sciences, 1976
- Restoration of specific immunity against SV40 tumor‐specific transplantation antigen to lymphoid cells from tumor‐bearing miceInternational Journal of Cancer, 1975
- In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivoEuropean Journal of Immunology, 1973
- Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (l1210) miceInternational Journal of Cancer, 1971